|
TEX10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.5276000000033E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.770200E-04 |
| Normal-vs-Stage2 |
3.035200E-03 |
| Normal-vs-Stage3 |
3.061900E-03 |
| Normal-vs-Stage4 |
3.62449999999903E-05 |
| Stage1-vs-Stage2 |
2.718600E-01 |
| Stage1-vs-Stage3 |
8.295600E-01 |
| Stage1-vs-Stage4 |
2.929500E-02 |
| Stage2-vs-Stage3 |
4.346000E-01 |
| Stage2-vs-Stage4 |
4.693600E-01 |
| Stage3-vs-Stage4 |
8.936400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.642000E-04 |
| Normal-vs-AfricanAmerican |
2.260200E-01 |
| Normal-vs-Asian |
7.962500E-03 |
| Caucasian-vs-AfricanAmerican |
3.829600E-01 |
| Caucasian-vs-Asian |
8.867600E-01 |
| AfricanAmerican-vs-Asian |
4.318400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.003410E-03 |
| Normal-vs-Female |
1.232850E-04 |
| Male-vs-Female |
9.707200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.146320E-02 |
| Normal-vs-Age(41-60Yrs) |
4.973900E-04 |
| Normal-vs-Age(61-80Yrs) |
3.75810000000643E-05 |
| Normal-vs-Age(81-100Yrs) |
6.190500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.544200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.822200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.054150E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.659450E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.244200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.122000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.522800E-01 |
| Classical-VS-Follicular |
3.62200000000312E-05 |
| Classical-VS-Other |
4.402600E-01 |
| Classical-VS-Normal |
2.876000E-02 |
| Tall-VS-Follicular |
1.732210E-01 |
| Tall-VS-Other |
8.670200E-01 |
| Tall-VS-Normal |
8.875500E-03 |
| Follicular-VS-Other |
5.632000E-01 |
| Follicular-VS-Normal |
5.63149999965873E-07 |
| Other-VS-Normal |
7.559800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.23649999999687E-05 |
| Normal-vs-N1 |
1.771370E-04 |
| N0-vs-N1 |
3.144800E-01 |
|
|
